Search research articles
Contact Us
Filters
Showing results (141-150 of 169) with videos related to
Page
of 17
Sort By:
Bioorganic Chemistry
|
December 19, 2025
Metabolomics accelerates drug development and facilitates the discovery of new targets, mechanisms and structures
Yu Zhou, Ziwei Xu, Baichen Xiong, et al.
European Journal of Medicinal Chemistry
|
May 31, 2014
2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1)
Jinlei Bian, Bang Deng, Lili Xu, et al.
European Journal of Medicinal Chemistry
|
October 12, 2022
Design, synthesis and evaluation of fused hybrids with acetylcholinesterase inhibiting and Nrf2 activating functions for Alzheimer's disease
Yuanyuan Wang, Baichen Xiong, Hongzhi Lin, et al.
Bioorganic & Medicinal Chemistry
|
May 18, 2026
PROTACs for central nervous system disorders: challenges and opportunities
Na Zheng, Jikuan Shao, Baichen Xiong, et al.
European Journal of Medicinal Chemistry
|
November 19, 2019
Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases
Qi Li, Shuaishuai Xing, Ying Chen, et al.
Bioorganic & Medicinal Chemistry
|
September 28, 2013
Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors
Xiaoke Guo, Qian Yang, Jing Xu, et al.
European Journal of Medicinal Chemistry
|
May 17, 2024
Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies
Yuqing Wei, Sheng Zhong, Huajing Yang, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor
Qi Li, Shuaishuai Xing, Ying Chen, et al.
Journal of Medicinal Chemistry
|
February 22, 2023
Design and Synthesis of Sulfonium Derivatives: A Novel Class of α-Glucosidase Inhibitors with Potent In Vivo Antihyperglycemic Activities
Lu Lu, Jingyi Chen, Wenxiang Tao, et al.
Acta Pharmaceutica Sinica. B
|
October 6, 2025
Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer's disease
Anže Meden, Neža Žnidaršič, Damijan Knez, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 169) with videos related to
Sort By:
Page
of 17
Bioorganic Chemistry
|
December 19, 2025
Metabolomics accelerates drug development and facilitates the discovery of new targets, mechanisms and structures
Yu Zhou, Ziwei Xu, Baichen Xiong, et al.
European Journal of Medicinal Chemistry
|
May 31, 2014
2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1)
Jinlei Bian, Bang Deng, Lili Xu, et al.
European Journal of Medicinal Chemistry
|
October 12, 2022
Design, synthesis and evaluation of fused hybrids with acetylcholinesterase inhibiting and Nrf2 activating functions for Alzheimer's disease
Yuanyuan Wang, Baichen Xiong, Hongzhi Lin, et al.
Bioorganic & Medicinal Chemistry
|
May 18, 2026
PROTACs for central nervous system disorders: challenges and opportunities
Na Zheng, Jikuan Shao, Baichen Xiong, et al.
European Journal of Medicinal Chemistry
|
November 19, 2019
Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases
Qi Li, Shuaishuai Xing, Ying Chen, et al.
Bioorganic & Medicinal Chemistry
|
September 28, 2013
Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors
Xiaoke Guo, Qian Yang, Jing Xu, et al.
European Journal of Medicinal Chemistry
|
May 17, 2024
Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies
Yuqing Wei, Sheng Zhong, Huajing Yang, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor
Qi Li, Shuaishuai Xing, Ying Chen, et al.
Journal of Medicinal Chemistry
|
February 22, 2023
Design and Synthesis of Sulfonium Derivatives: A Novel Class of α-Glucosidase Inhibitors with Potent In Vivo Antihyperglycemic Activities
Lu Lu, Jingyi Chen, Wenxiang Tao, et al.
Acta Pharmaceutica Sinica. B
|
October 6, 2025
Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer's disease
Anže Meden, Neža Žnidaršič, Damijan Knez, et al.
Page
of 17